ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411 | -8.9% | 15,293 | +20.9% | 0.03% | -13.9% |
| Q2 2023 | $451 | +20.9% | 12,646 | -13.8% | 0.04% | +33.3% |
| Q1 2023 | $373 | -34.2% | 14,679 | +5.0% | 0.03% | -42.6% |
| Q4 2022 | $567 | -99.9% | 13,978 | +13.2% | 0.05% | +23.7% |
| Q3 2022 | $408,000 | -19.2% | 12,351 | -13.9% | 0.04% | -17.4% |
| Q2 2022 | $505,000 | +71.2% | 14,347 | +123.4% | 0.05% | +360.0% |
| Q1 2022 | $295,000 | – | 6,421 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |